Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05668117 · ClinicalTrials.gov registry record
RFN-Advanced Retrograde Femoral Nailing System
A clinical trial of Femur Fracture, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 53
- Enrollment target
- 1
- Study location
NCT05668117 is a study of Femur Fracture that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 53 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05668117, a study of Femur Fracture, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 53 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a retrospective chart review of the safety and performance Standard of Care data on individuals that have previously been implanted with the femur nail of the RFNA System for the internal fixation of the femur. Demographics, medical history, primary diagnosis, mechanism of injury, type of injury, clinical and radiographic evaluation of bone consolidation, and device-related adverse events were collected. Descriptive statistics were applied to the data collected.
Conditions Studied
Interventions
- DEVICE Depuy Synthes Advanced Retrograde femoral nail
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2023-04-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05668117
The ClinicalTrials.gov registry entry for NCT05668117 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Femur Fracture appearing as the primary indexed condition, and to 1 intervention - of which Depuy Synthes Advanced Retrograde femoral nail is the first listed.
NCT05668117 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT05668117 about?
NCT05668117 is a clinical study titled "RFN-Advanced Retrograde Femoral Nailing System". This study is a retrospective chart review of the safety and performance Standard of Care data on individuals that have previously been implanted with the femur nail of the RFNA System for the internal fixation of the femur. Demographics, medical history, primary diagnosis, mechanism of injury, type...
What is the current status of trial NCT05668117?
This trial is currently completed. The enrollment target is 53 participants. The study started on 2021-02-01. Estimated completion is 2023-04-27.
What conditions does trial NCT05668117 study?
This clinical trial studies the following conditions: Femur Fracture.
What interventions are being tested in trial NCT05668117?
The interventions under investigation include: Depuy Synthes Advanced Retrograde femoral nail (DEVICE).
Who is sponsoring clinical trial NCT05668117?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05668117 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Femur Fracture
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.